Cleopatra Hospital Company is trading at $15.20 (0%) today following a sharp deterioration in its Q1 2026 financial results.
- Consolidated net profit for the first quarter fell 41.1% year-over-year to EGP 118.1 million, significantly missing performance expectations.
- Investor sentiment remains under pressure as the stock struggles to recover from a 2.4% drop in the previous session triggered by the disappointing earnings report.